Pharmaceutical / Drug Definition :
Reduces inflammation, possibly by suppressing cell-mediated immune reactions; decreasing white blood cell, monocyte, and eosinophil counts; reducing binding of immunoglobulins to cell surface receptors; and inhibiting interleukin synthesis. Also stabilizes lysosomal membranes, curbs polymorphonuclear leukocyte migration, interrupts phagocytosis, and diminishes antibody formation in infected and injured tissues.
FDA Label Requirements and Exceptions
FDA Import Information
Cortisone Acetate (Cortisone Acetate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Cortisone Acetate (Cortisone Acetate Suppliers)
- Processors Cortisone Acetate
- Repackers Cortisone Acetate
- Relabelers Cortisone Acetate
- Exporters Cortisone Acetate
- Importers Cortisone Acetate
For more information about Cortisone Acetate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.